Table 4.
N | PY | AD | aHR (95% CI) | |
---|---|---|---|---|
Model 1* | ||||
No NSAID | 9,501 | 47,293 | 642 | 1.0 |
SALA alone | 2,544 | 14,828 | 127 | 0.82 (0.67 – 0.99) |
Non-SALA alone | 743 | 4,162 | 25 | 0.60 (0.40 – 0.90) |
Both SALA & non-SALA | 573 | 3,704 | 23 | 0.87 (0.57 – 1.33) |
Unclassifiable alone | 96 | 556 | 3 | 0.61 (0.19 – 1.89) |
Model 2* | ||||
No NSAID | 9,501 | 47,293 | 642 | 1.0 |
Any ibuprofen | 2,093 | 12,731 | 103 | 0.88 (0.71 – 1.09) |
Other than ibuprofen | 1,863 | 10,518 | 75 | 0.67 (0.53 – 0.86) |
Model 3* | ||||
No NSAID | 9,501 | 47,293 | 642 | 1.0 |
Any naproxen | 806 | 4,887 | 22 | 0.55 (0.36 – 0.85) |
Other than naproxen | 3,150 | 18,363 | 156 | 0.82 (0.69 – 0.99) |
aHR=adjusted hazard ratio, N=number, PY=person years, AD=incident Alzheimer’s dementia, CI=confidence interval, NSAID=non-steroidal anti-inflammatory drug, SALA=selective Aβ42-lowering agent
Each model shows the relationship between a medication classification and the risk of incident AD. All models are stratified by study and adjusted for age, sex, and education. The variables shown within each model are mutually exclusive categorizations of the medication exposure of interest.
Data on NSAID type missing for 42 participants